Free Trial

Coronavirus vaccine breakthrough as.....>

MARKET TALK
MARKET TALK: Coronavirus vaccine breakthrough as Oxford scientists discover jab
which could protect against virus for decades (Telegraph)
- Oxford scientists believe they have made a breakthrough in their quest for a
Covid-19 vaccine after discovering that the jab triggers a response that may
offer a "double defence" against the virus. Phase I human trials of the
world-leading Oxford vaccine have shown that it generates an immune response
against the disease, the Telegraph has learned. Blood samples taken from a group
of UK volunteers given a dose of the vaccine showed that it stimulated the body
to produce both antibodies and 'killer T-cells', a senior source said. The
discovery is promising because separate studies have suggested that antibodies
may fade away within months while T-cells can stay in circulation for years.
However the source cautioned that the results, while "extremely promising", did
not yet prove that the Oxford vaccine provides long-lasting immunity against
Covid-19.
- Link: https://tinyurl.com/y8ylfcov
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.